Paul joined Christie & Co’s corporate medical team in 2014. He was made director in 2017 and was later appointed as head of dental in the UK, leading an expanding multi-disciplinary team of agents and advisors across the country, spearheading the brokerage side of the dental business, and driving significant, high-profile transactions, including Queensway Group’s partnership with Dentex and a recent large portfolio of BUPA divestments.
In Paul’s new position, he will oversee the entirety of Christie & Co’s medical services offering – from brokerage to valuation – which includes key sectors such as dentistry, pharmacy, General Practice, and veterinary services.
The role was previously held by Simon Hughes, who led the company’s expansion into pharmacy, dentistry, GP surgeries and other ‘white coat’ sectors in 2013. Simon has now moved into the role of commercial director, where he will help develop and improve key business areas.
Darren Bond, global managing director at Christie & Co, commented, “Huge congratulations to Paul on this senior appointment. Our medical team has been market-leading with its dental and pharmacy activity in recent years, and I have every confidence that the business will continue to increase its market share under Paul’s leadership. I’d also like to thank Simon for establishing such an incredible team over the last 10 years and I look forward to working together with him in his new strategic role.”
Paul commented, “I am delighted to be appointed to this position. I have had the distinct privilege of working closely with Simon, witnessing firsthand the remarkable impact he has made in our medical sector, and I’m deeply grateful for his contributions and stewardship. Our team’s success has been immense and is a testament to the amazing efforts and expertise of the colleagues within - for this, I am incredibly grateful. I also want to express my sincere appreciation to our valued clients, as your steadfast support has been a cornerstone of our progress. My commitment to our business spans across dental, pharmacy, and medical valuations, and as I embark on this new chapter, I am energised to drive continued development and growth in our medical sector, building on our strong heritage.”